Use of Misoprostol in Hysteroscopic Myomectomy, a Randomized Peospective Trial

NCT06049745 Phase 4 NOT_YET_RECRUITING

Hysteroscopic myomectomy is typically suitable for myomas measuring under 4 cm in size. The utilization of misoprostol before the procedure can facilitate uterine access, decrease fluid absorption, and reduce blood loss, consequently leading to a decrease in the overall procedure time. In this randomized trial, the investigators aim to investigate the impact of misoprostol administration and its effects on each of the mentioned parameters.

Details

Lead sponsor	Assuta Ashdod Hospital
Phase	Phase 4
Status	NOT_YET_RECRUITING
Enrolment	200
Start date	2023-11
Completion	2026-10

Conditions

• Hysteroscopic Myomectomy

Interventions

• Misoprostol 400 Microgram Oral Tablet

Primary outcomes

• length of the procedure — from the first insertion of the hysteroscope to the end of the procedure, minutes
  overall procedure time

Countries

Israel